VMCPX yields 1.16% · JNJ yields 3.36%● Live data
📍 VMCPX pulled ahead of the other in Year 1
Combined, VMCPX + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of VMCPX + JNJ for your $10,000?
This low-cost index fund provides broad mid-capitalization U.S. equity exposure. The fund seeks to track an index of medium-sized companies, whose stocks tend to be more volatile than those of larger companies. This potential volatility is one of the fund’s key risks. Investors looking to add a passively managed, mid-cap stock allocation to an already diversified portfolio may wish to consider this fund.
Full VMCPX Calculator →Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.